Postdoctoral Fellowship Grants
Funding Amount
Not stated
Deadline
Expected ~December
Based on past cycles
Grant Type
Foundation
Deadline history & next window
- Cycle
- Rolling — applications accepted year-round
- Current deadline
- December 31, 2027
- Tracked since
- April 2026
From the program guidelines: “Review of applications conducted on a rolling basis through Fall 2026”
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Candidates who have received their MD degree or PhD degree from a U.S. medical or graduate school or equivalent educational institution
Other requirements
- Early-career scientists with demonstrated commitment to scleroderma research
- Quality of research proposal is a primary consideration
Overview
Duration: Two-year fellowships
Geographic Scope: United States (MD or PhD from U.S. institution)
Focus Areas: Scleroderma research
Eligibility:
- Candidates who have received their MD degree or PhD degree from a U.S. medical or graduate school or equivalent educational institution
- Early-career scientists with demonstrated commitment to scleroderma research
- Quality of research proposal is a primary consideration
Application Requirements:
- Applications must be accompanied by a letter from the sponsoring lead investigator underscoring the commitment to scleroderma research
Background: The SRF is dedicated to bringing talented early-career scientists to the field of scleroderma research. Several SRF-funded fellows and recipients of an Early Career Grant are now dedicating themselves to the field of scleroderma research.
How to Apply
Application Process
Timeline:
- 2026 cycle deadline: March 31, 2026 (CLOSED)
- 2027 cycle applications will be available by the end of 2026 or early 2027
- Review of applications conducted on a rolling basis through Fall 2026
- Funding awarded between July – December 2026
Required Materials:
- Research proposal demonstrating quality and innovative approach
- Letter from sponsoring lead investigator emphasizing commitment to scleroderma research
Application Guidelines:
- See "Application Guidelines" link on website for detailed requirements
Contact for Questions: grants@srfcure.org
What Scleroderma Research Foundation actually gave
Source: IRS Form 990, 2025
- Grants in 2025
- 26
- Total given
- $3.77M
- Median grant
- $112K
- Range
- $11K–$467K
- By dollars: California 33%, New York 11%, Pennsylvania 11%. Top recipient cities: New York, NY; San Francisco, CA; Dallas, TX.
- 0% of grants with a stated purpose were for general or operating support.
- 8% of recipients were new grantees, not repeat recipients.
Example grants
Regents of Univ of CA-UCSF · San Francisco, CA
Research
$467K
Stanford School of Medicine · San Francisco, CA
Research
$460K
University of Utah · Salt Lake City, UT
Research
$366K
Univ of TX Health Science Ctr · Dallas, TX
Research
$314K
Regents of Univ of Michigan · Pittsburgh, PA
Research
$218K
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Established Investigator and New Faculty Grants
Scleroderma Research Foundation
Amount
Varies
Deadline
Expected ~December
Based on past cycles
Early Career Grants
Scleroderma Research Foundation
Amount
Varies
Deadline
Expected ~December
Based on past cycles
SSCD-CDF Fellowship Grant Award
Celiac Disease Foundation
Amount
Varies
Deadline
Deadline not published
Atlas Fellowship Program
Atlas Fellowship Inc
Amount
Varies
Deadline
Deadline not published
SSCD-CDF Visiting Celiac Disease Fellowship Program
Celiac Disease Foundation
Amount
Varies
Deadline
Deadline not published
ISSCD-Celiac Disease Foundation Research Fellowship Award
Celiac Disease Foundation
Amount
Varies
Deadline
Deadline not published
Ready to apply for Postdoctoral Fellowship Grants?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Postdoctoral Fellowship Grants. Now let's win it.